the cellular level. Its POLARIS system is designed for both preclinical and clinical applications, supporting earlier assessment of treatment response, particularly in cancer care. NVision Imaging also explores applications of metabolic MRI in cardiology, neurology, hepatology, nephrology, and rheumatology by enabling faster detection of physiological changes associated with disease and treatment. The company combines expertise in quantum physics, imaging technology, and medical research to develop tools that integrate with existing MRI infrastructure.